Discrimination between fibrin and fibrinogen by a monoclonal antibody against a synthetic peptide. 1985

U Scheefers-Borchel, and G Müller-Berghaus, and P Fuhge, and R Eberle, and N Heimburger

Circulating soluble fibrin, observed in the blood of patients with ongoing intravascular coagulation, is generated from the plasma protein fibrinogen by the limited proteolytic action of thrombin. We report the production of a monoclonal antibody that discriminates between fibrin and fibrinogen in blood. The synthetic hexapeptide Gly-Pro-Arg-Val-Val-Glu, representing the amino terminus of the alpha chain of human fibrin, was used as immunogen. This hexapeptide is located within the A alpha chain of fibrinogen but becomes the amino terminus of the fibrin alpha chain, after fibrinopeptide A is removed by the action of thrombin, and thus becomes accessible for antibody binding. The monoclonal antibody we have prepared can discriminate between fibrin and fibrinogen and thus can be used in assay systems to quantitate soluble fibrin or, potentially, to image fibrin-rich thrombi.

UI MeSH Term Description Entries
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D005337 Fibrin A protein derived from FIBRINOGEN in the presence of THROMBIN, which forms part of the blood clot. Antithrombin I
D005340 Fibrinogen Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products. Coagulation Factor I,Factor I,Blood Coagulation Factor I,gamma-Fibrinogen,Factor I, Coagulation,gamma Fibrinogen
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000936 Antigen-Antibody Complex The complex formed by the binding of antigen and antibody molecules. The deposition of large antigen-antibody complexes leading to tissue damage causes IMMUNE COMPLEX DISEASES. Immune Complex,Antigen-Antibody Complexes,Immune Complexes,Antigen Antibody Complex,Antigen Antibody Complexes,Complex, Antigen-Antibody,Complex, Immune,Complexes, Antigen-Antibody,Complexes, Immune
D000939 Epitopes Sites on an antigen that interact with specific antibodies. Antigenic Determinant,Antigenic Determinants,Antigenic Specificity,Epitope,Determinant, Antigenic,Determinants, Antigenic,Specificity, Antigenic

Related Publications

U Scheefers-Borchel, and G Müller-Berghaus, and P Fuhge, and R Eberle, and N Heimburger
December 1983, Science (New York, N.Y.),
U Scheefers-Borchel, and G Müller-Berghaus, and P Fuhge, and R Eberle, and N Heimburger
November 1983, Molecular immunology,
U Scheefers-Borchel, and G Müller-Berghaus, and P Fuhge, and R Eberle, and N Heimburger
October 1990, Casopis lekaru ceskych,
U Scheefers-Borchel, and G Müller-Berghaus, and P Fuhge, and R Eberle, and N Heimburger
April 2020, Journal of neuroendocrinology,
U Scheefers-Borchel, and G Müller-Berghaus, and P Fuhge, and R Eberle, and N Heimburger
January 2013, Human antibodies,
U Scheefers-Borchel, and G Müller-Berghaus, and P Fuhge, and R Eberle, and N Heimburger
September 1995, Thrombosis and haemostasis,
U Scheefers-Borchel, and G Müller-Berghaus, and P Fuhge, and R Eberle, and N Heimburger
November 1987, FEBS letters,
U Scheefers-Borchel, and G Müller-Berghaus, and P Fuhge, and R Eberle, and N Heimburger
April 1990, Hybridoma,
U Scheefers-Borchel, and G Müller-Berghaus, and P Fuhge, and R Eberle, and N Heimburger
February 1985, American journal of hematology,
U Scheefers-Borchel, and G Müller-Berghaus, and P Fuhge, and R Eberle, and N Heimburger
December 1986, Thrombosis research,
Copied contents to your clipboard!